Tag: clinical study
Clinical Trial to Evaluate Experimental Treatment in People Allergic to Multiple...
NIH and partners to assess whether Omalizumab can reduce allergic reactions.
Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food...
First clinical study of a bacterial consortium for treating food allergy will initially be studied in patients with history of peanut allergy.
Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...
Trial results demonstrate excellent PVX108 safety profile in patients with prior anaphylaxis and current asthma.
Phase 3 Trial Data Demonstrates Consistent Safety and Efficacy of AR101...
“Results of the European ARTEMIS trial provide further clinical validation of the safety and efficacy of AR101 for children and adolescents with peanut allergy.”
Aimmune Therapeutics Presents New AR101 Data Including Demonstrated Reduction in Accidental...
AR101-Treated Patients Who Completed PALISADE Had 95% Increased Probability of Tolerating Any Dose of Peanut Protein in Exit Challenge Compared to Placebo.
Phase I Trial for New Peanut Allergy Immunotherapy Results in No...
Research details phase one study of peptide-based immunotherapy, which is designed to remove risks of acute reactions during treatment.
Aimmune to Begin Phase 2 Trials of Egg Allergy OIT Candidate
AR201 for Egg Allergy Phase 2 Initiation Planned for 2019.
Can Fecal Transplant Cure Peanut Allergy? Phase I Trial Underway
Can transplanting the microbiota of a healthy person to that of an allergic individual prevent allergic reactions?
Aimmune Therapeutics Announces Initiation of Phase 2 Study of AR101 With...
Trial Will Build on the Positive, Pivotal Phase 3 PALISADE Trial of AR101.
Phase II Trials of AR101 with Dupilumab for Peanut Allergy to...
Study scheduled to commence next week.
